T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Broadcom
AVGO
|
+$3.01B |
| 2 |
Gilead Sciences
GILD
|
+$1.25B |
| 3 |
Accenture
ACN
|
+$1.09B |
| 4 |
XYZ
Block, Inc.
XYZ
|
+$1.06B |
| 5 |
Valero Energy
VLO
|
+$1.05B |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$3.94B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.84B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.47B |
| 4 |
Eli Lilly
LLY
|
+$1.43B |
| 5 |
Tesla
TSLA
|
+$1.4B |
Sector Composition
| 1 | Technology | 30.49% |
| 2 | Healthcare | 13.92% |
| 3 | Financials | 12.27% |
| 4 | Consumer Discretionary | 10.96% |
| 5 | Communication Services | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RGLS
2901
DELISTED
Regulus Therapeutics
RGLS
| $52K | ﹤0.01% |
29,597
| – | – |
|
2902
Tenaya Therapeutics
TNYA
$196M
| $52K | ﹤0.01% |
89,570
-46,664
| -34% | -$27.1K |
|
|
WGSWW
2903
GeneDx Holdings Corp. Warrant
WGSWW
$2.5M
| $52K | ﹤0.01% |
243,780
-7,150
| -3% | -$1.53K |
|
2904
Arq
ARQ
$306M
| $52K | ﹤0.01% |
12,457
+2,127
| +21% | +$8.88K |
|
2905
Alta Equipment Group
ALTG
$239M
| $51K | ﹤0.01% |
10,872
+409
| +4% | +$1.92K |
|
2906
Design Therapeutics
DSGN
$343M
| $51K | ﹤0.01% |
13,069
+618
| +5% | +$2.41K |
|
2907
Editas Medicine
EDIT
$242M
| $51K | ﹤0.01% |
43,777
| – | – |
|
2908
CS Disco
LAW
$357M
| $51K | ﹤0.01% |
12,365
+641
| +5% | +$2.64K |
|
2909
PLAYSTUDIOS Inc
MYPS
$121M
| $51K | ﹤0.01% |
39,525
| – | – |
|
|
ONL
2910
Orion Office REIT
ONL
$168M
| $51K | ﹤0.01% |
23,650
+886
| +4% | +$1.91K |
|
2911
BRC Inc
BRCC
$183M
| $50K | ﹤0.01% |
23,207
+974
| +4% | +$2.1K |
|
2912
Perspective Therapeutics
CATX
$258M
| $50K | ﹤0.01% |
23,440
+3,748
| +19% | +$8K |
|
|
IGMS
2913
DELISTED
IGM Biosciences
IGMS
| $50K | ﹤0.01% |
42,864
-3,526,135
| -99% | -$4.11M |
|
2914
Nerdy
NRDY
$158M
| $48K | ﹤0.01% |
33,611
+3,348
| +11% | +$4.78K |
|
2915
Rackspace Technology
RXT
$347M
| $48K | ﹤0.01% |
27,938
+1,131
| +4% | +$1.94K |
|
2916
Cassava Sciences
SAVA
$102M
| $48K | ﹤0.01% |
31,427
-4,939
| -14% | -$7.54K |
|
2917
Ampco-Pittsburgh
AP
$53.6M
| $47K | ﹤0.01% |
21,600
| – | – |
|
2918
Clarus
CLAR
$147M
| $46K | ﹤0.01% |
12,069
| – | – |
|
2919
AlTi Global
ALTI
$388M
| $45K | ﹤0.01% |
14,567
+893
| +7% | +$2.76K |
|
2920
Nkarta
NKTX
$140M
| $45K | ﹤0.01% |
23,958
| – | – |
|
2921
Gold Resource Corp
GORO
$112M
| $44K | ﹤0.01% |
84,700
| – | – |
|
2922
WM Technology
MAPS
$131M
| $44K | ﹤0.01% |
38,765
| – | – |
|
2923
Future Fuel
FF
$169M
| $43K | ﹤0.01% |
10,860
+705
| +7% | +$2.79K |
|
2924
Lexicon Pharmaceuticals
LXRX
$418M
| $43K | ﹤0.01% |
92,248
+14,746
| +19% | +$6.87K |
|
|
OPI
2925
Office Properties Income Trust
OPI
$40.8M
| $43K | ﹤0.01% |
92,441
+41,400
| +81% | +$19.3K |
|